Prostaglandin‑associated periorbitopathy.
dc.contributor.author | Shrirao, Neha | |
dc.contributor.author | Khurana, Mona | |
dc.contributor.author | Mukherjee, Bipasha | |
dc.date.accessioned | 2016-12-05T07:49:54Z | |
dc.date.available | 2016-12-05T07:49:54Z | |
dc.date.issued | 2016-06 | |
dc.identifier.citation | Shrirao Neha, Khurana Mona, Mukherjee Bipasha. Prostaglandin‑associated periorbitopathy. Indian Journal of Ophthalmology. 2016 June; 64(6): 459. | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/179319 | |
dc.language.iso | en | en_US |
dc.source.uri | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991179/ | en_US |
dc.subject | Antiglaucoma medication | en_US |
dc.subject | fat atrophy | en_US |
dc.subject | periorbitopathy | en_US |
dc.subject | prostaglandin analogs | en_US |
dc.subject | ptosis | en_US |
dc.title | Prostaglandin‑associated periorbitopathy. | en_US |
dc.type | Article | en_US |